Can oral 1,25(OH)2D3 pulse therapy reduce parathyroid hyperplasia? 1991

T Hyodo, and K Ono, and T Koumi, and M Ueda, and I Miyagawa, and K Kodani, and S Doi, and M Ishibashi, and T Morita

UI MeSH Term Description Entries
D006962 Hyperparathyroidism, Secondary Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY. Secondary Hyperparathyroidism,Hyperparathyroidisms, Secondary,Secondary Hyperparathyroidisms
D006965 Hyperplasia An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. Hyperplasias
D010280 Parathyroid Glands Two pairs of small oval-shaped glands located in the front and the base of the NECK and adjacent to the two lobes of THYROID GLAND. They secrete PARATHYROID HORMONE that regulates the balance of CALCIUM; PHOSPHORUS; and MAGNESIUM in the body. Gland, Parathyroid,Glands, Parathyroid,Parathyroid Gland
D002117 Calcitriol The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (CALCIFEDIOL). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption. 1 alpha,25-Dihydroxycholecalciferol,1 alpha,25-Dihydroxyvitamin D3,1, 25-(OH)2D3,1,25(OH)2D3,1,25-Dihydroxycholecalciferol,1,25-Dihydroxyvitamin D3,1 alpha, 25-dihydroxy-20-epi-Vitamin D3,1,25(OH)2-20epi-D3,1,25-dihydroxy-20-epi-Vitamin D3,20-epi-1alpha,25-dihydroxycholecaliferol,Bocatriol,Calcijex,Calcitriol KyraMed,Calcitriol-Nefro,Decostriol,MC-1288,MC1288,Osteotriol,Renatriol,Rocaltrol,Silkis,Sitriol,Soltriol,Tirocal,1 alpha,25 Dihydroxyvitamin D3,1,25 Dihydroxycholecalciferol,1,25 Dihydroxyvitamin D3,1,25 dihydroxy 20 epi Vitamin D3,Calcitriol Nefro,D3, 1 alpha,25-Dihydroxyvitamin,D3, 1,25-Dihydroxyvitamin,D3, 1,25-dihydroxy-20-epi-Vitamin,KyraMed, Calcitriol,MC 1288
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations

Related Publications

T Hyodo, and K Ono, and T Koumi, and M Ueda, and I Miyagawa, and K Kodani, and S Doi, and M Ishibashi, and T Morita
February 1991, Nihon Jinzo Gakkai shi,
T Hyodo, and K Ono, and T Koumi, and M Ueda, and I Miyagawa, and K Kodani, and S Doi, and M Ishibashi, and T Morita
January 1989, Nephron,
T Hyodo, and K Ono, and T Koumi, and M Ueda, and I Miyagawa, and K Kodani, and S Doi, and M Ishibashi, and T Morita
April 1993, Nihon Jinzo Gakkai shi,
T Hyodo, and K Ono, and T Koumi, and M Ueda, and I Miyagawa, and K Kodani, and S Doi, and M Ishibashi, and T Morita
September 1987, Kidney international,
T Hyodo, and K Ono, and T Koumi, and M Ueda, and I Miyagawa, and K Kodani, and S Doi, and M Ishibashi, and T Morita
June 1988, Kidney international,
T Hyodo, and K Ono, and T Koumi, and M Ueda, and I Miyagawa, and K Kodani, and S Doi, and M Ishibashi, and T Morita
July 1989, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
T Hyodo, and K Ono, and T Koumi, and M Ueda, and I Miyagawa, and K Kodani, and S Doi, and M Ishibashi, and T Morita
November 1985, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
T Hyodo, and K Ono, and T Koumi, and M Ueda, and I Miyagawa, and K Kodani, and S Doi, and M Ishibashi, and T Morita
December 1979, Research communications in chemical pathology and pharmacology,
T Hyodo, and K Ono, and T Koumi, and M Ueda, and I Miyagawa, and K Kodani, and S Doi, and M Ishibashi, and T Morita
January 1989, Haematologica,
T Hyodo, and K Ono, and T Koumi, and M Ueda, and I Miyagawa, and K Kodani, and S Doi, and M Ishibashi, and T Morita
January 1994, Sheng li ke xue jin zhan [Progress in physiology],
Copied contents to your clipboard!